Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥282.81 Million ≈ $41.38 Million USD) by net assets (CN¥9.60 Billion ≈ $1.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600521 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Zhejiang Huahai Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Genscript Biotech Corporation
F:G51
-0.024x
Impinj Inc
NASDAQ:PI
0.072x
Jiangsu Aucksun Co Ltd
SHE:002245
0.036x
Kinik Co
TW:1560
0.048x
GPGI, Inc.
NYSE:GPGI
-0.017x
Dolby Laboratories
NYSE:DLB
0.134x
AllianceBernstein Holding L.P.
NYSE:AB
0.061x
MERCARI INC. UNSP.ADR/1/2
F:6TP0
-0.048x

Annual Cash Flow Conversion Efficiency for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600521 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥9.46 Billion
≈ $1.38 Billion
CN¥1.23 Billion
≈ $180.00 Million
0.130x -45.99%
2024-12-31 CN¥9.02 Billion
≈ $1.32 Billion
CN¥2.17 Billion
≈ $317.93 Million
0.241x -10.35%
2023-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥2.22 Billion
≈ $324.42 Million
0.269x +67.47%
2022-12-31 CN¥7.75 Billion
≈ $1.13 Billion
CN¥1.24 Billion
≈ $181.85 Million
0.160x +15.85%
2021-12-31 CN¥6.78 Billion
≈ $991.59 Million
CN¥938.43 Million
≈ $137.32 Million
0.138x -40.13%
2020-12-31 CN¥6.72 Billion
≈ $983.95 Million
CN¥1.56 Billion
≈ $227.61 Million
0.231x -23.78%
2019-12-31 CN¥5.78 Billion
≈ $845.61 Million
CN¥1.75 Billion
≈ $256.66 Million
0.304x +1780.57%
2018-12-31 CN¥4.21 Billion
≈ $615.58 Million
CN¥67.90 Million
≈ $9.94 Million
0.016x -85.06%
2017-12-31 CN¥5.05 Billion
≈ $739.67 Million
CN¥546.24 Million
≈ $79.93 Million
0.108x +14.22%
2016-12-31 CN¥4.58 Billion
≈ $669.88 Million
CN¥433.10 Million
≈ $63.38 Million
0.095x +80.21%
2015-12-31 CN¥3.72 Billion
≈ $544.40 Million
CN¥195.31 Million
≈ $28.58 Million
0.052x -47.82%
2014-12-31 CN¥3.27 Billion
≈ $477.93 Million
CN¥328.61 Million
≈ $48.09 Million
0.101x -38.04%
2013-12-31 CN¥3.02 Billion
≈ $441.82 Million
CN¥490.29 Million
≈ $71.75 Million
0.162x +29.80%
2012-12-31 CN¥1.95 Billion
≈ $285.21 Million
CN¥243.83 Million
≈ $35.68 Million
0.125x -3.12%
2011-12-31 CN¥1.53 Billion
≈ $223.82 Million
CN¥197.51 Million
≈ $28.90 Million
0.129x -43.15%
2010-12-31 CN¥1.32 Billion
≈ $192.92 Million
CN¥299.47 Million
≈ $43.82 Million
0.227x -13.25%
2009-12-31 CN¥1.21 Billion
≈ $177.39 Million
CN¥317.44 Million
≈ $46.45 Million
0.262x +243.02%
2008-12-31 CN¥1.10 Billion
≈ $161.41 Million
CN¥84.20 Million
≈ $12.32 Million
0.076x -45.45%
2007-12-31 CN¥975.52 Million
≈ $142.75 Million
CN¥136.52 Million
≈ $19.98 Million
0.140x +57.99%
2006-12-31 CN¥875.40 Million
≈ $128.10 Million
CN¥77.54 Million
≈ $11.35 Million
0.089x +33.34%
2005-12-31 CN¥802.34 Million
≈ $117.41 Million
CN¥53.30 Million
≈ $7.80 Million
0.066x -68.13%
2004-12-31 CN¥785.53 Million
≈ $114.95 Million
CN¥163.73 Million
≈ $23.96 Million
0.208x +201.31%
2003-12-31 CN¥685.42 Million
≈ $100.30 Million
CN¥47.41 Million
≈ $6.94 Million
0.069x -92.60%
2002-12-31 CN¥80.56 Million
≈ $11.79 Million
CN¥75.34 Million
≈ $11.02 Million
0.935x +79.90%
2001-12-31 CN¥72.15 Million
≈ $10.56 Million
CN¥37.51 Million
≈ $5.49 Million
0.520x --

About Zhejiang Huahai Pharmaceutical Co Ltd

SHG:600521 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.36 Billion
CN¥22.98 Billion CNY
Market Cap Rank
#4651 Global
#826 in China
Share Price
CN¥15.35
Change (1 day)
-2.29%
52-Week Range
CN¥14.46 - CN¥27.01
All Time High
CN¥43.62
About

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and pol… Read more